The present teaching provide indazole compounds represented by Structural Formulae (I) or (I') or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as TTK protein kinase, polo-like kinase 4 (PLK4) and Aurora kinases having anticancer activity against breast cancer cells, colon cancer cells, and ovarian cancer cells.
本教学提供了由结构式(I)或(I')表示的
吲唑化合物或其药用可接受的盐。还描述了这些药物组合物及其用作蛋白激酶
抑制剂的方法,如对乳腺癌细胞、结肠癌细胞和卵巢癌细胞具有抗癌活性的
TTK蛋白激酶、极化样激酶4(PLK4)和极化激酶。